Clinical trials are the foundation for getting needed drug and medical treatments to market. However, a new global survey found that disjointed technologies and undue complexity in sharing information and training is stalling outcomes.
“Sites are overwhelmed with too many solutions and ballooning login credentials,” said Jim Kremidas, executive director, ACRP. “Instead of engaging with patients, an inordinate amount of time is spent learning new systems, completing redundant required training and reentering the same data multiple times.
